NCT01099319已完成3 期
Efficacy and Safety of Renalof Administration in the Treatment of Elderly Patients With Gallstones
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Catalysis SL
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Size of calculi at month 0 and 6 (month 0 refers to the beginning of treatment and month 6 refers to the end of the treatment)
研究概览
简要总结
The purpose of this study is to assess the efficacy and safety of Renalof administration in the treatment of gallstones (cholelithiasis) as determined by ultrasonography and clinical evaluation in elderly patients (aged >65 years). The duration of this double-blind placebo controlled phase 3 clinical trial will be 6 months. The estimated number of patients to be recruited and randomized for the study is 40.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Confirmation of cholelithiasis by ultrasonography with or without clinical symptoms.
- •Signed informed consent
排除标准
- •Previous surgical intervention for the treatment of cholelithiasis
- •Cholelithiasis with acute symptoms requiring emergency surgery
- •Cholelithiasis associated with neoplastic condition of any localization or origin
- •Usage of other antioxidants within the duration of the clinical trial
- •Handicap and/or psychiatric condition preventing treatment accomplishment
结局指标
主要结局
Size of calculi at month 0 and 6 (month 0 refers to the beginning of treatment and month 6 refers to the end of the treatment)
时间窗: 6 month
Number of calculi at month 0 and 6 (month 0 refers to the beginning of treatment and month 6 refers to the end of the treatment)
时间窗: 6 month
次要结局
- Presence of digestive symptoms associated with cholelithiasis(6 month)
- Occurrence of adverse effects during treatment(6 month)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis BChronic Hepatitis BNCT00116805Gilead Sciences266
已完成
4 期
Study Evaluating ReFacto® in Hemophilia A Undergoing Major SurgeryHemophilia ANCT00092976Wyeth is now a wholly owned subsidiary of Pfizer15
已完成
2 期
Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral SclerosisALSNCT03472950University of Kansas Medical Center14
已完成
不适用
Safety and Effectiveness of RegorafenibNeoplasmsNCT02042144Bayer1,034
已完成
3 期
Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e AntigenHBeAg-negative Chronic Hepatitis BNCT01940341Gilead Sciences426